Biology of Blood and Marrow Transplantation
Volume 9, Issue 11 , Pages 669-673 , November 2003

The source of cells for allografting

  • Stephen Couban

      Affiliations

    • Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    • Corresponding Author InformationCorrespondence and reprint requests: Stephen Couban, MD, Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Room 417, Bethune Building, 1278 Tower Rd., Halifax, Nova Scotia, Canada B3H 2Y9
    • ,
  • Michael Barnett

      Affiliations

    • Department of Medical Oncology, St. Bartholomew’s Hospital, London, UK England

Received 27 May 2003 ,Accepted 27 August 2003.

References 

  1. Schmitz N, Linch DC, Dreger P, et al.  Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet. 1996;347:353–357
  2. Vose JM, Sharp G, Chan WC, et al.  Autologous transplantation for aggressive non-Hodgkin’s lymphoma (results of a randomized trial evaluating graft source and minimal residual disease). J Clin Oncol. 2002;20:2344–2352
  3. Bensinger WI, Weaver CH, Appelbaum FR, et al.  Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood. 1995;85:1655–1658
  4. Korbling M, Przepiorka D, Huh YO, et al.  Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma (potential advantage of blood over marrow allografts). Blood. 1995;85:1659–1665
  5. Schmitz N, Dreger P, Suttorp M, et al.  Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood. 1995;85:1666–1672
  6. Champlin RE, Schmitz N, Horowitz MM, et al.  Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood. 2000;95:3702–3709
  7. Vigorito AC, Azevedo WM, Marques JF, et al.  A randomized prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant. 1998;22:1145–1151
  8. Mahmoud HK, Fahmy OA, Kamel A, Kamel M, El-Haddad A, El-Kadi D. Peripheral blood vs. bone marrow as a source for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 1999;24:355–358
  9. Blaise D, Kuentz M, Fortanier C, et al.  Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia (a report from the Société Française de Greffe de Moelle). J Clin Oncol. 2000;18:537–546
  10. Heldal D, Tjonnfjord GE, Brinch L, et al.  A randomized study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant. 2000;25:1129–1136
  11. Powles R, Mehta J, Kulkarni S, et al.  Allogeneic blood and bone marrow stem-cell transplantation in haematological malignant diseases: (a randomized trial). Lancet. 2000;355:1231–1237
  12. Bensinger WI, Martin PJ, Storer B, et al.  Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med. 2001;344:175–181
  13. Couban S, Simpson DR, Barnett MJ, et al.  A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood. 2002;100:1525–1531
  14. Schmitz N, Beksac M, Hasenclever D, et al.  Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood. 2002;100:761–767
  15. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft-versus-host disease after allogeneic peripheral blood stem cell and bone marrow transplantation (a meta-analysis). J Clin Oncol. 2001;19:3685–3691
  16. Lapierre V, Oubouzar N, Aupérin A, et al.  Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation. Blood. 2001;97:2580–2586
  17. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood. 1997;89:3891–3893
  18. Storek J, Dawson MA, Storer B, et al.  Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood. 2001;91:3380–3389
  19. Storek J, Witherspoon RP, Maloney DG, Chauncey TR, Storb R. Improved reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow. [letter] Blood. 1997;89:3891–3893
  20. Arpinati M, Green C, Heimfeld S, Heuser JE, Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood. 2000;95:2484–2490
  21. Pan L, Delmonte J, Jalonen CK, Ferrara JL. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood. 1995;86:4422–4429
  22. Ringden O, Remberger M, Runde V, et al.  Peripheral blood stem cell transplantation from unrelated donors (a comparison with marrow transplantation). Blood. 1999;94:455–464
  23. Remberger M, Ringden O, Blau IW, et al.  No difference in graft-versus-host disease, relapse and survival comparing peripheral blood stem cells to bone marrow using unrelated donors. Blood. 2001;98:1739–1745
  24. Anderlini P, Przepiorka D, Champlin R, et al.  Biologic and clinical effects of granulocyte colony stimulating factor in normal individuals. Blood. 1996;88:2819–2825
  25. Falanga A, Marchetti M, Evangelista V, et al.  Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony stimulating factor. Blood. 1999;93:2506–2514
  26. Anderlini P, Körbling M, Dale D, et al.  Allogeneic blood stem cell transplantation (considerations for donors). Blood. 1997;90:903–908
  27. Cavallaro AM, Lilleby IT, Majolino I, et al.  Three to six year follow-up of normal donors who received recombinant human granulocyte colony stimulating factor. Bone Marrow Transplant. 2000;5:85–89
  28. Becker PS, Wagle M, Matous S, et al.  Spontaneous splenic rupture following administration of granulocyte colony stimulating factor (G-CSF) (occurrence in an allogeneic donor of peripheral blood stem cells). Biol Blood Marrow Transplant. 1997;3:45–49
  29. Falzetti F, Aversa F, Minelli O, Tabilio A. Spontaneous rupture of spleen during peripheral blood stem cell mobilisation in a healthy donor. [research letter] Lancet. 1999;353–355
  30. Couban S, Messner HA, Andreou P, et al.  Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients (a study of 29 patients). Biol Blood Marrow Transplant. 2000;6:422–427
  31. Isola L, Scigliano E, Fruchtman S. Long-term follow-up after allogeneic granulocyte colony-stimulating factor-primed bone marrow transplantation. Biol Blood Marrow Transplant. 2000;6:428–433
  32. Serody JS, Sparks SD, Lin Y, et al.  Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant. 2000;6:434–440
  33. Morton J, Hutchins C, Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow (significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells). Blood. 2001;98:3186–3191

PII: S1083-8791(03)00333-1

doi: 10.1016/j.bbmt.2003.08.012

Biology of Blood and Marrow Transplantation
Volume 9, Issue 11 , Pages 669-673 , November 2003

Article Tools